Brompheniramine

Routes
Oral (PO)
Half-Life (t½)
PO: 25h
Formula
C16H19BrN2
Molecular Weight
319.24 g/mol
PubChem CID
6834
Aliases
Dimetapp

Pharmacological Mechanism

First-generation H1 antagonist — bromine analog of chlorpheniramine. OTC component of multi-ingredient cold formulations. Same sedation + anticholinergic profile.

Half-Life & Elimination Curve (PO: 25h)

100%50%25%12.5%0%0h0×t½25h1×t½50h2×t½3.1d3×t½4.2d4×t½5.2d5×t½0×t½ (0h): 100% remaining (~3.22 µg/L)1×t½ (25h): 50% remaining (~1.61 µg/L)2×t½ (50h): 25% remaining (~0.804 µg/L)3×t½ (3.1d): 12.5% remaining (~0.402 µg/L)4×t½ (4.2d): 6.3% remaining (~0.201 µg/L)5×t½ (5.2d): 3.1% remaining (~0.1 µg/L)
Plasma (PO)t½ Decay (25h)
  • 0×t½0h100% (3.22 µg/L)
  • 1×t½25h50% (1.61 µg/L)
  • 2×t½50h25% (0.804 µg/L)
  • 3×t½3.1d12.5% (0.402 µg/L)
  • 4×t½4.2d6.3% (0.201 µg/L)
  • 5×t½5.2d3.1% (0.1 µg/L)
Elimination t½25h (PO)
Rate Constant (ke)0.0277 h⁻¹
Time to Peak (Tmax)2.17h
Est. Peak (Cmax)3.22 µg/L
Clearance (CL)22.7 L/h
97% Washout (5×t½)5.2d

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References